Provided by Tiger Trade Technology Pte. Ltd.

Williams

70.49
-1.1900-1.66%
Post-market: 70.540.0500+0.07%19:50 EDT
Volume:7.59M
Turnover:537.43M
Market Cap:86.08B
PE:28.08
High:73.32
Open:72.17
Low:69.92
Close:71.68
52wk High:80.08
52wk Low:56.09
Shares:1.22B
Float Shares:1.21B
Volume Ratio:1.23
T/O Rate:0.62%
Dividend:2.05
Dividend Rate:2.91%
EPS(TTM):2.51
EPS(LYR):2.14
ROE:21.50%
ROA:5.03%
PB:6.54
PE(LYR):32.94

Loading ...

Feb 25, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Major Issues Report

8-K - Current report
Dec 09, 2020

Major Issues Report

8-K - Current report
Nov 02, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2020

Major Issues Report

8-K - Current report
Aug 03, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2020

Major Issues Report

8-K - Current report
Jun 11, 2020

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
May 14, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Major Issues Report

8-K - Current report
May 12, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 08, 2020

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
May 04, 2020

Major Issues Report

Current report, items 8.01 and 9.01
May 04, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 04, 2020

Major Issues Report

Current report, items 2.02 and 9.01